Investigation into the RAtio of LDL-CHolestEroL to HDL-Cholesterol improvement after statin treatment in Korean patients - RACHEL
Study identifier:NIS-CKR-DUM-2009/3
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Investigation into the RAtio of LDL-CHolestEroL to HDL-Cholesterol improvement after statin treatment in Korean patients
Medical condition
Dyslipidemias
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
3000
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Jul 2009
Primary Completion Date: -
Study Completion Date: 01 Sept 2009
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 3000 patients Who have at least made 1 visit to the outpatient clinic within previous 6 months . | - |
Contacts
Investigators
Principal Investigator
Hyunah Caroline Choi
AstraZeneca Korea
